Analystreport

Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Evercore ISI from $4.00 to $3.00. They now have an "in-line" rating on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report